Urinary β2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial NephritisDaisuke Nagata, Kentaro Oka, Kyohei Misawa et al.|Internal Medicine|2025Cited by 0